V001-4670 Screening compound: 4-(2H-1,3-benzodioxol-5-yl)-2-(4-{2-[(4-methylphenyl)sulfanyl]pyridine-3-carbonyl}piperazin-1-yl)pyrimidine

V001-4670 Screening compound: 4-(2H-1,3-benzodioxol-5-yl)-2-(4-{2-[(4-methylphenyl)sulfanyl]pyridine-3-carbonyl}piperazin-1-yl)pyrimidine
V001-4670 Screening compound: 4-(2H-1,3-benzodioxol-5-yl)-2-(4-{2-[(4-methylphenyl)sulfanyl]pyridine-3-carbonyl}piperazin-1-yl)pyrimidine alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-4670
4-(2H-1,3-benzodioxol-5-yl)-2-(4-{2-[(4-methylphenyl)sulfanyl]pyridine-3-carbonyl}piperazin-1-yl)pyrimidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-4670

Molecular Formula

C28H25N5O3S (C28 H25 N5 O3 S)

Compound Name

4-(2H-1,3-benzodioxol-5-yl)-2-(4-{2-[(4-methylphenyl)sulfanyl]pyridine-3-carbonyl}piperazin-1-yl)pyrimidine

IUPAC name

4-(2H-13-benzodioxol-5-yl)-2-(4-{2-[(4-methylphenyl)sulfanyl]pyridine-3-carbonyl}piperazin-1-yl)pyrimidine

SMILES

Cc(cc1)ccc1Sc1ncccc1C(N(CC1)CCN1c1nc(-c(cc2)cc3c2OCO3)ccn1)=O

InChI

InChI=1S/C28H25N5O3S/c1-19-4-7-21(8-5-19)37-26-22(3-2-11-29-26)27(34)32-13-15-33(16-14-32)28-30-12-10-23(31-28)20-6-9-24-25(17-20)36-18-35-24/h2-12,17H,13-16,18H2,1H3

InChI Key

RPMVFOROBIRING-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19942772

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

511.6

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.316

Distribution Coefficient, logD

5.315

Water Solubility, LogSw

-5.26

Polar Surface Area

63.829

Acid Dissociation Constant (pKa)

21.00

Base Dissociation Constant (pKb)

4.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.40

V001-4670 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V001-4670 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-4670?
Check Price and Availability of V001-4670, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-4670 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-4670
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-4670
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-4670 available by request